FP330APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS. (13th June 2019) - Kalantar-Zadeh, Kamyar; Zoccali, Carmine; Beddhu, Srinivasan; Brandenburg, Vincent; Haarhaus, Mathias; Tonelli, Marcello; Khan, Aziz; Halliday, Christopher; Lebioda, Ken; Johansson, Jan O; Sweeney, Michael; Wong, Norman C W; et al.